Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0032 USD
Change Today 0.00 / 0.00%
Volume 521.2K
ITNS On Other Exchanges
As of 5:20 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

itonis inc (ITNS) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/11/14 - $0.02
52 Week Low
08/26/15 - $0.0028
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ITONIS INC (ITNS)

Related News

No related news articles were found.

itonis inc (ITNS) Related Businessweek News

No Related Businessweek News Found

itonis inc (ITNS) Details

Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.

3 Employees
Last Reported Date: 05/15/12
Founded in 2005

itonis inc (ITNS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

itonis inc (ITNS) Key Developments

Migranade To Acquire World Wide Rights Of Itonis

Migranade, Inc. is in negotiations to acquire worldwide rights manufacture and market EMESYL™ Nausea Relief from Itonis Inc. (OTCPK:ITNS).

Itonis Pharmaceuticals Authorizes Start of Emesyl(R) Inaugural Production Run

Itonis Inc. announced that, with the finalization of its new packaging design and product labeling, it has given the go ahead to Oasis Health Products to produce 16,000 units of its Emesyl(R) homeopathic product. Itonis has pre-paid necessary funds to Oasis to commence the inaugural production run.

Itonis Inc. Receives NDC Number from FDA to Enable Production and Marketing of Emesyl(R) Product

Itonis Inc. announced that the U.S. Food & Drug Administration (FDA) has published final approval of the company's National Drug Code (NDC) number (59067-001) for its Emesyl(R) over-the-counter homeopathic product for nausea relief. In addition, the company recently received a notice of allowance from the U.S. Patent & Trademark Office for its Emesyl(R) trademark. The NDC number and trademark Notice of Allowance has enabled the Company to enter the final stage of its product packaging design, and the production of Emesyl(R) will soon begin with its manufacturer, Oasis Health Products. The company will market Emesyl(R) to national retailers, including drugstore retailers, department stores, cruiselines, and other strategic retail sectors upon receiving its first production batch from Oasis. Plans are in place to aggressively market Emesyl(R) for a significant share of the worldwide over-the-counter pharmaceutical market revenues.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ITNS:US $0.00 USD 0.00

ITNS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ITNS.
View Industry Companies

Industry Analysis


Industry Average

Valuation ITNS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ITONIS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at